The Russian national research center that is developing a vaccine to combat covid-19 has finished clinical trials and will move on to its registration phase, the Russian Health Minister announced today.
“The vaccine against the new coronavirus developed by the National Research Center for Epidemiology and Microbiology Gamalei has completed clinical trials and we are now preparing documents for registration,” said Mikhail Murashko, quoted by the TASS agency.
The Russian minister said doctors and teachers will receive the first doses of the vaccine.
Mikhail Murashko hopes that the vaccine will be sent to the different regions of Russia as of August 10, while another vaccine, to be developed by the state center Véctor, is still in the process of clinical tests.
The Health Minister expects to receive “next month and a half or two months” two new applications for authorization to carry out clinical trials of new vaccines, with a view to an extended vaccination campaign to begin in October.
On Friday, the main United States epidemiologist, Anthony Fauci, said he hoped that China and Russia “are really testing” vaccines developed to combat covid-19 “before delivering them to anyone.”
The observation by the director of the US National Institute of Allergies and Infectious Diseases came shortly after Russian authorities secured the next approval of the new coronavirus vaccine, ahead of the United States.
The covid-19 pandemic has already claimed more than 673,000 deaths and infected more than 17.3 million people in 196 countries and territories, according to a report by the French agency AFP.
Russia accounts for 13,939 deaths in more than 838,000 cases, making it the fourth country in the world in number of infected people, after the USA, Brazil and India.
The disease is transmitted by a new coronavirus detected in late December in Wuhan, a city in central China.